Stock Taper
SCREENER COMPARE ANY 2 STOCKS
DRMA
DERMATA THERAPEUTICS, INC.
NASDAQ
$1.34
▼ DOWN 8.22% (-0.12)

KEY STATISTICS

Market Cap$913.29 K
52w High$6.22
52w Low$0.95
Dividend Yield—
Frequency—
P/E-0.31
Volume102.24K
Shares Out.681.56K

COMPANY

LEADERSHIP

Gerald T. Proehl
CHIEF EXECUTIVE
Gerald T. Proehl

COMPENSATION 2026

Salary$280,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$392,000

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 13, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
9

PRICE TARGET

Target High$6.00
Target Low$6.00
Target Median$6.00
Target Consensus$6.00

UPCOMING EARNINGS

DateNov 18, 2026
DayWednesday
Rev. Est.$25.00K
NOV
18
WED

SPLIT RECORD

DATETYPERATIO
2025-08-01Reverse1:10
2024-05-16Reverse1:15
2023-03-14Reverse1:16

PRICE

$1.34 ▼ DOWN 8.22% (−$0.12)
OVERLAYS
$1.35$1.40$1.45$1.509:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.34

About Dermata Therapeutics, Inc.

https://www.dermatarx.com ↗

Dermata Therapeutics, Inc. is a San Diego-based biotech developing pharmaceutical candidates like DMT310 and DMT410 for skin conditions such as acne, psoriasis, rosacea, and hyperhidrosis.

INDUSTRY

Biotechnology

A PRODUCT DERMATA THERAPEUTICS, INC. IS KNOWN FOR

Once-weekly acne kit
Once-weekly acne kit

Dermata Therapeutics is developing a once-weekly OTC acne treatment kit using proprietary Spongilla technology, shifting focus from prescription drugs to target the large consumer acne market after withdrawing its Phase 3 drug candidate XYNGARI™.

COMPETITORS

COMPETITOR
ABBV COMPARE
BHC COMPARE
SLGL COMPARE
SSKN COMPARE
VY VYNE COMPARE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
—
HOLDERS
1
TOP 1 OF 1 · RANKED BY POSITION SIZE
Concourse Financial Group Securities, Inc.
0 sh · $0

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER, OFFICER: PRESIDENT, CHAIRMAN, CEO
PROEHL GERALD T
Purchase · 1.4M shares
2026-08-16
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: PRESIDENT, CHAIRMAN, CEO
PROEHL GERALD T
Purchase · 170.1K shares
2026-08-16
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: PRESIDENT, CHAIRMAN, CEO
PROEHL GERALD T
Purchase · 170.1K shares
2026-08-16
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: PRESIDENT, CHAIRMAN, CEO
PROEHL GERALD T
Purchase · 170.1K shares
2026-08-16

SECTORS PEERS

PEERPRICE
VRAX$2.82COMPARE
GTBP$0.30COMPARE
REVB$1.05COMPARE
ELAB$5.31COMPARE
ARTL$0.66COMPARE
ATXI$0.45COMPARE
PBM$4.21COMPARE
CARM$0.00COMPARE